- Home
- TLSI vs NIU Comparison
TLSI vs NIU Comparison
Compare TLSI & NIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLSI | NIU |
|---|---|---|
| Founded | 2010 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 244.3M | 275.6M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | TLSI | NIU |
|---|---|---|
| Price | $5.91 | $3.26 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $11.50 | N/A |
| AVG Volume (30 Days) | 212.5K | ★ 816.4K |
| Earning Date | 11-13-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $40,207,000.00 | ★ $625,182,280.00 |
| Revenue This Year | $55.06 | $42.51 |
| Revenue Next Year | $46.04 | $23.71 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 49.52 | ★ 50.99 |
| 52 Week Low | $3.42 | $1.66 |
| 52 Week High | $7.95 | $5.67 |
Technical Indicators
Market Signals| Indicator | TLSI | NIU |
|---|---|---|
| Relative Strength Index (RSI) | 38.84 | 48.18 |
| Support Level | $5.60 | $3.02 |
| Resistance Level | $7.20 | $3.38 |
| Average True Range (ATR) | 0.48 | 0.16 |
| MACD | -0.23 | 0.04 |
| Stochastic Oscillator | 12.98 | 74.26 |
Price Performance
Historical ComparisonAbout TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About NIU Niu Technologies
Niu Technologies designs, manufactures and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycle, mopeds and bicycle series, including the NQi, MQi, UQi, F series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.